Literature DB >> 9354805

Insulin VNTR allele-specific effect in type 1 diabetes depends on identity of untransmitted paternal allele. The IMDIAB Group.

S T Bennett1, A J Wilson, L Esposito, N Bouzekri, D E Undlien, F Cucca, L Nisticò, R Buzzetti, E Bosi, F Pociot, J Nerup, A Cambon-Thomsen, A Pugliese, J P Shield, P A McKinney, S C Bain, C Polychronakos, J A Todd.   

Abstract

The IDDM2 type 1 diabetes susceptibility locus was mapped to and identified as allelic variation at the insulin gene (INS) VNTR regulatory polymorphism. In Caucasians, INS VNTR alleles divide into two discrete size classes. Class I alleles (26 to 63 repeats) predispose in a recessive way to type 1 diabetes, while class III alleles (140 to more than 200 repeats) are dominantly protective. The protective effect may be explained by higher levels of class III VNTR-associated INS mRNA in thymus such that elevated levels of preproinsulin protein enhance immune tolerance to preproinsulin, a key autoantigen in type 1 diabetes pathogenesis. The mode of action of IDDM2 is complicated, however, by parent-of-origin effects and possible allelic heterogeneity within the two defined allele classes. We have now analysed transmission of specific VNTR alleles in 1,316 families and demonstrate that a particular class I allele does not predispose to disease when paternally inherited, suggestive of polymorphic imprinting. But this paternal effect is observed only when the father's untransmitted allele is a class III. This allelic interaction is reminiscent of epigenetic phenomena observed in plants (for example, paramutation; ref. 17) and in yeast (for example, trans-inactivation; ref. 18). If untransmitted chromosomes can have functional effects on the biological properties of transmitted chromosomes, the implications for human genetics and disease are potentially considerable.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9354805     DOI: 10.1038/ng1197-350

Source DB:  PubMed          Journal:  Nat Genet        ISSN: 1061-4036            Impact factor:   38.330


  37 in total

Review 1.  Genetic predisposition to IDDM.

Authors:  S Caillat-Zucman; J F Bach
Journal:  Clin Rev Allergy Immunol       Date:  2000-12       Impact factor: 8.667

2.  Age and sex based genetic locus heterogeneity in type 1 diabetes.

Authors:  A D Paterson; A Petronis
Journal:  J Med Genet       Date:  2000-03       Impact factor: 6.318

Review 3.  Genomic imprinting: implications for human disease.

Authors:  J G Falls; D J Pulford; A A Wylie; R L Jirtle
Journal:  Am J Pathol       Date:  1999-03       Impact factor: 4.307

Review 4.  Above and within the genome: epigenetics past and present.

Authors:  F D Urnov; A P Wolffe
Journal:  J Mammary Gland Biol Neoplasia       Date:  2001-04       Impact factor: 2.673

Review 5.  The marks, mechanisms and memory of epigenetic states in mammals.

Authors:  V K Rakyan; J Preis; H D Morgan; E Whitelaw
Journal:  Biochem J       Date:  2001-05-15       Impact factor: 3.857

6.  Transgenerational inheritance of epigenetic states at the murine Axin(Fu) allele occurs after maternal and paternal transmission.

Authors:  Vardhman K Rakyan; Suyinn Chong; Marnie E Champ; Peter C Cuthbert; Hugh D Morgan; Keith V K Luu; Emma Whitelaw
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-24       Impact factor: 11.205

7.  The regulatory regions required for B' paramutation and expression are located far upstream of the maize b1 transcribed sequences.

Authors:  Maike Stam; Christiane Belele; Wusirika Ramakrishna; Jane E Dorweiler; Jeffrey L Bennetzen; Vicki L Chandler
Journal:  Genetics       Date:  2002-10       Impact factor: 4.562

Review 8.  Molecular aspects of type 1 diabetes.

Authors:  M A Kelly; M L Rayner; C H Mijovic; A H Barnett
Journal:  Mol Pathol       Date:  2003-02

Review 9.  Genetic susceptibility in type 1 diabetes and its associated autoimmune disorders.

Authors:  Akane Ide; George S Eisenbarth
Journal:  Rev Endocr Metab Disord       Date:  2003-09       Impact factor: 6.514

Review 10.  Candidate genes for type 2 diabetes.

Authors:  Hemang Parikh; Leif Groop
Journal:  Rev Endocr Metab Disord       Date:  2004-05       Impact factor: 6.514

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.